Table 1.
Patient Characteristics
| N | Percent | ||
|---|---|---|---|
| Total Eligible | 74 | ||
| Age | Median (Range) | 71 (48–90) | |
| Race | Caucasian | 66 | 89.2 |
| African American | 7 | 9.5 | |
| Asian | 1 | 1.4 | |
| ECOG Performance | 0 | 31 | 41.9 |
| 1 | 39 | 52.7 | |
| 2 | 4 | 5.4 | |
| Metastatic Disease | Bidimensional, Measurable | 35 | 47.3 |
| Osseous, Evaluable | 63 | 85.1 | |
| Disease Sites | Bone | 64 of 74 | 86.5 |
| Lymph Nodes | 26 of 68 | 38.2 | |
| Lung | 9 of 69 | 13.0 | |
| Liver | 8 of 72 | 11.1 | |
| Elevated PSA (ng/ml) | 73 | 98.7 | |
| Median | 151.1 | ||
| Interquartile Range | 63.7 – 536.0 | ||
| Hemoglobin (U/L) | Median | 12.8 | |
| Interquartile Range | 11.6–13.8 | ||
| Radiotherapy | To Metastatic Site | 17 | 23.0% |